RankAlpha logo
Back to Rankings

NEO

NeoGenomicsD
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
The earnings release supports a constructive operating thesis: double-digit revenue growth, 26% NGS growth, improving adjusted EBITDA, higher average revenue per clinical test, and raised full-year guidance. The advanced-testing mix and pending reimbursement opportunities could support further growth.
Posture
Defensive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-10-28 · AMC.
What can break
Clinical volume growth may not keep pace with pricing and mix benefits.
Momentum
52
Value
41
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $18.50 · Bull $21.00 · Bear $13.25Analysis 2026-07-31; returns require an exact persisted reference.
Earnings
2026-10-28 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-31 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $21.95
Why
Momentum52 · Δ7d -26.7
Value41 · Δ7d +0.1
Sentiment53 · Δ7d +1.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-10-28 · AMC.
  • • Sentiment remains the lead driver in the composite, 7D delta +1.4.

Contradictions & invalidation

  • • Clinical volume growth may not keep pace with pricing and mix benefits.
  • • Convertible notes may increase dilution or create future capital-structure pressure.
  • • Clinical volume increased only 2%, while reported GAAP net income was just $2 million and benefited from an $11 million debt-extinguishment gain.

Catalyst clock

2026-10-28 · AMC

Q2 earnings showed durable growth and raised FY2026 guidance

Lead driver: Sentiment · See AI snapshot
Momentum
52
8% active weight
Current posture
7d trendSoftening
Δ7d
-26.7
Δ21d
-47.2
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.3
Sentiment
53
45% active weight
Current posture
7d trendSoftening
Δ7d
+1.4
Δ21d
+3.2
Why this grade

Composite grade D. Momentum 52.4 / Value 41.4 / Sentiment 52.7

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-31. Scenario method

B+
Bull case
25%
Probability
Target price
$21.00
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$18.50
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$13.25
Analysis reference price unavailable
Analysis 2026-07-31 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$2.13B
Beta
1.57
Shares Out
128.48M
P/E (TTM) · Derived
-19.7
P/S (TTM)
2.20
P/FCF (TTM) · Derived
-284.56
Rev YoY
+11.2%
EPS YoY
-104.9%
Gross Margin
+41.7%
Op Margin
-7.0%
Net Debt
$249.84M
Current Ratio
3.60
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data